Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.

In persons with HIV/AIDS (PWHAs), Hodgkin lymphoma (HL) risk is increased. However, HL incidence in PWHAs has unexpectedly increased since highly active antiretroviral therapy (HAART) was introduced. We linked nationwide HIV/AIDS and cancer registry data from 1980 through 2002. Immunity was assessed by CD4 T-lymphocyte counts at AIDS onset. Annual HL incidence rates were calculated for 4 through 27 months after AIDS onset. During 477 368 person years (py's) of follow-up in 317 428 persons with AIDS (PWAs), 173 HL cases occurred (36.2 per 10(5) py's). Incidence was significantly higher in 1996 to 2002 than earlier. Incidence in PWAs with 150 to 199 CD4 cells/muL was 53.7 per 10(5) py's, whereas in PWAs with fewer than 50 CD4 cells/muL, it was 20.7 per 10(5) py's (P(trend) = .002). For each HL subtype, incidence decreased with declining CD4 counts, but nodular sclerosing decreased more precipitously than mixed cellularity, thereby increasing the proportion of mixed cellularity HL seen in PWAs. We conclude that HL incidence is lower with severe immunosuppression than with moderate immunosuppression, and HAART-related improvements in CD4 counts likely explain the increasing HL incidence in PWHAS observed since 1996. With more severe immunosuppression, nodular sclerosing HL becomes infrequent, explaining the higher proportion of mixed cellularity HL found in PWAs. Pathogenesis implications are discussed.

[1]  J. Fraumeni,et al.  Cancer epidemiology and prevention. , 2006 .

[2]  J. Goedert,et al.  Trends in cancer risk among people with AIDS in the United States 1980–2002 , 2006, AIDS.

[3]  P. Gaulard,et al.  Mediastinal Gray Zone Lymphoma: The Missing Link Between Classic Hodgkin's Lymphoma and Mediastinal Large B-Cell Lymphoma , 2005, The American journal of surgical pathology.

[4]  Jonathan AC Sterne,et al.  Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study , 2005, The Lancet.

[5]  Olivia Keiser,et al.  Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. , 2005, Journal of the National Cancer Institute.

[6]  E. Jaffe,et al.  Molecular Profiling Provides Evidence of Primary Mediastinal Large B-Cell Lymphoma as a Distinct Entity Related to Classic Hodgkin Lymphoma: Implications for Mediastinal Gray Zone Lymphomas as an Intermediate Form of B-Cell Lymphoma , 2004, Advances in anatomic pathology.

[7]  Terri Wrin,et al.  The prevalence of antiretroviral drug resistance in the United States , 2004, AIDS.

[8]  R. Biggar,et al.  Cancer Risk in Elderly Persons With HIV/AIDS , 2004, Journal of acquired immune deficiency syndromes.

[9]  T. Golub,et al.  The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. , 2003, Blood.

[10]  A. Telenti,et al.  CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. , 2003, Archives of internal medicine.

[11]  L. Staudt,et al.  Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma , 2003, The Journal of experimental medicine.

[12]  D. Costagliola,et al.  Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  S. Franceschi,et al.  Incidence of AIDS-Defining Cancers After AIDS Diagnosis Among People with AIDS in Italy, 1986–1998 , 2003, Journal of acquired immune deficiency syndromes.

[14]  M. Gulley,et al.  Population‐based patterns of human immunodeficiency virus‐related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988–1998 , 2003, Cancer.

[15]  T. Mak,et al.  The role of cytokines in classical Hodgkin lymphoma. , 2002, Blood.

[16]  X. Mariette,et al.  Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. , 2002, Blood.

[17]  J. Kaldor,et al.  Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis , 2002, AIDS.

[18]  D. Hossfeld.  E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues , 2002 .

[19]  A Muñoz,et al.  Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts. , 2001, American journal of epidemiology.

[20]  J. Goedert,et al.  Association of cancer with AIDS-related immunosuppression in adults. , 2001, JAMA.

[21]  W. Chan.  The Reed–Sternberg cell in classical Hodgkin's disease , 2001, Hematological oncology.

[22]  J. Margolick,et al.  Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis , 2001, AIDS.

[23]  J. Fleishman,et al.  Prevalence and Predictors of Highly Active Antiretroviral Therapy Use in Patients With HIV Infection in the United States , 2000 .

[24]  J. Fleishman,et al.  Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization. , 2000, Journal of acquired immune deficiency syndromes.

[25]  S. Franceschi,et al.  Cancer risk among men with, or at risk of, HIV infection in southern Europe , 2000, AIDS.

[26]  E. Jaffe,et al.  Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  A. van den Berg,et al.  High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. , 1999, The American journal of pathology.

[28]  H. Stein,et al.  Hodgkin's disease: biology and origin of Hodgkin and Reed-Sternberg cells. , 1999, Cancer treatment reviews.

[29]  A. Telenti,et al.  Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study , 1999, The Lancet.

[30]  M. Spittle.  Spectrum of AIDS-associated malignant disorders , 1998, The Lancet.

[31]  J. Goedert,et al.  Spectrum of AIDS-associated malignant disorders , 1998, The Lancet.

[32]  A. Zauber,et al.  Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978-1990. , 1996, American journal of epidemiology.

[33]  L. Kingsley,et al.  Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  R. Warnke,et al.  Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. , 1993, The New England journal of medicine.

[35]  Jennifer Y. Liu,et al.  Increased Incidence of Hodgkin Disease in Homosexual Men with HIV Infection , 1992, Annals of Internal Medicine.

[36]  Dr. Ron Short.  Diagnosis? , 1987, The Lancet.

[37]  J. Goedert,et al.  Cancer in a group at risk of acquired immunodeficiency syndrome (AIDS) through 1984. , 1987, American journal of epidemiology.

[38]  Giffen Jw.  Hodgkin's disease , 1980, Bone Marrow Transplantation.

[39]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[40]  John McGrath,et al.  Hodgkin’s Disease , 1933, JAMA.

[41]  A. Telenti,et al.  CD 4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years The Swiss HIV Cohort Study , 2003 .

[42]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[43]  R. Coutinho,et al.  Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults , 2000 .

[44]  V. Beral,et al.  Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. , 2000 .

[45]  V. Beral,et al.  Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. , 2000, Journal of the National Cancer Institute.

[46]  A. van den Berg,et al.  Immune escape mechanisms in Hodgkin's disease. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[47]  G. Lemp,et al.  The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco, 1980-1987. , 1993, American journal of epidemiology.